Login / Signup
Yin Wang
ORCID
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 4
Top Topics
Acute Myeloid Leukemia
Weight Loss
Epidermal Growth Factor Receptor
Drug Administration
Top Venues
Cancer research communications
Oncogene
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jonelle K Lee
,
Aditi Chatterjee
,
Mario Scarpa
,
Christopher M Bailey
,
Sandrine Niyongere
,
Prerna Singh
,
Moaath K Mustafa Ali
,
Shivani Kapoor
,
Yin Wang
,
Giovannino Silvestri
,
Maria R Baer
Pim kinase inhibitors increase gilteritinib cytotoxicity in FLT3-ITD acute myeloid leukemia through GSK-3β activation and c-Myc and Mcl-1 proteasomal degradation.
Cancer research communications
(2024)
Jonelle K Lee
,
Aditi Chatterjee
,
Mario Scarpa
,
Christopher M Bailey
,
Sandrine Niyongere
,
Prerna Singh
,
Moaath K Mustafa Ali
,
Shivani Kapoor
,
Yin Wang
,
Giovannino Silvestri
,
Maria R Baer
Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation.
Cancer research communications
4 (2) (2024)
Jonelle K Lee
,
Aditi Chatterjee
,
Mario Scarpa
,
Christopher M Bailey
,
Sandrine Niyongere
,
Prerna Singh
,
Moaath K Mustafa Ali
,
Shivani Kapoor
,
Yin Wang
,
Giovannino Silvestri
,
Maria R Baer
Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation.
Cancer research communications
4 (2) (2024)
Yan Liu
,
Marie V Nelson
,
Christopher Bailey
,
Peng Zhang
,
Pan Zheng
,
Jeffrey S Dome
,
Yang Liu
,
Yin Wang
Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor.
Oncogene
40 (29) (2021)